Tuesday, December 07, 2004 6:32:51 PM
from web site:
Mario Pino, CEO/Founder - Mario Pino is the visionary leader of Mellon Research. He has ten years
of experience structuring and negotiating multi-million dollar contractual relationships with companies
in diverse industries, including real-estate, manufacturing, financial services, high tech and retail. Mr.
Pino has lived, worked and built revenue producing relationships with customers in Europe, Asia and
South America. He has successfully arranged and issued collateral for project funding via finance
structures tailored to meet client's objective in amounts ranging from $5M to $120M USD with
companies in diverse countries, including Thailand, China and the UK.
Mr. Pino has utilized traditional and web based marketing to generate a lead flow from potential client
companies, then worked closely with the CEOs and Board Members to structure short term financing,
secured by the client's fixed assets - enabling the client to gain temporary relief from restricted cash
flow and to have sufficient resources to complete projects on time and under budget and/or execute
their tactical business processes. He has extensive experience working with CEO and BOD
members developing business plans, restructuring their companies, and/or reworking their
operational plans to help the client go public via NASDAQ and/or the OTC markets. He has established
relationships with such top tier banking institutions as: HSBC (Hong Kong Securities Banking
Corporation), Royal Bank of Canada, Bank One Corporation, Dresser Bank, Deutsche Bank and Merrill
Lynch.
During his tenure with Alexander Estate and Trust in the 1999-2003 timeframe he worked closely
with some of the largest and most successful banking institutions and private trust companies in the
world to create financial packages for SMB companies to ensure credit facilities that were
established for a client would meet time requirements specified by the client and by ****** Wall Street
Securities ****** firms. During this period he also established and managed a network of 200 associates
located in key markets all over the world, developing successful joint ventures that generated a
strong deal flow and revenue stream for the company.
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM